You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Toll-like receptor 8 (TLR8)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • Nivolumab
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Dec 16, 2021

Testicular Torsion and TLR 4 Was Investigated Trial (Toll-like receptor 4)

Completed
  • Testicular Torsion and TLR 4 Was Investigated
  • Toll-like receptor 4
  • (no location specified)
Sep 23, 2022

Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)

Not yet recruiting
  • Spondylitis
  • Tuberculosis
  • 400 IU
  • +3 more
  • Makassar, South Sulawesi, Indonesia
    Wahidin Sudirohusodo General Hospital
May 11, 2022

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 20, 2021

Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Radiation
  • +2 more
  • New York, New York
    New York University Medical Center
Oct 25, 2021

Among HIV-1-infected Individuals With Previous or Current

Recruiting
  • Covid19
  • +2 more
  • Immune response study
  • Madrid, Spain
    Hospital Ramon y Cajal
Oct 23, 2021

Associated With Necrotizing Enterocolitis

Unknown status
  • Neonatal Disease
  • Gene expression of inflammatory mediator (Interleukin 8) and recognition receptor of Toll like receptor (TLR4).
  • (no location specified)
Sep 10, 2019

Cancer, Tumors Trial in Berlin (GSK1795091, Placebo)

Completed
Has Results
  • Cancer
  • Neoplasms
  • Berlin, Germany
    GSK Investigational Site
Nov 13, 2020

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023

Ovarian Cancer Trial in Switzerland, United States (Durvalumab, Pegylated Liposomal Doxorubicin, Motolimod)

Completed
Has Results
  • Ovarian Cancer
  • Phoenix, Arizona
  • +4 more
Aug 9, 2021

HIV Trial in Tygerberg Hills (HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix)

Recruiting
  • HIV Infections
  • HIVIS DNA/MVA-CMDR
  • +2 more
  • Tygerberg Hills, Cape Town, South Africa
    Stellenbosch University
Apr 20, 2022

Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

Recruiting
  • Hepatitis B
  • HIV Infections
  • San Diego, California
  • +35 more
Jan 31, 2023

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • Duarte, California
  • +12 more
Sep 21, 2022

Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

Recruiting
  • Ewing Sarcoma
  • +2 more
  • Peptide vaccine IPX
  • Frankfurt am Main, Germany
  • +2 more
Oct 18, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Durvalumab
  • Rintatolimod
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 23, 2023

Bladder Cancer Trial in Korea, Republic of, Poland, United States (PF-07225570, sasanlimab)

Recruiting
  • Bladder Cancer
  • New York, New York
  • +5 more
Jun 28, 2022

ASO and Beta-hemolytic Group A Streptococcus Infections in

Unknown status
  • Attention Deficit-Hyperactivity Disorder
  • Antistreptolysin O Test
  • +3 more
  • Orbassano, Torino, Italy
    AOU San Luigi Gonzaga di Orbassano
Mar 23, 2020

Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 12, 2023

Serum Lactate and Ulcerative Colitis

Recruiting
  • Ulcerative Colitis
  • serum lactate
  • Assiut, Egypt
    Ahmed Mohammed Abu-Elfatth
May 24, 2023

Immune Cell Response to Stimuli

Recruiting
  • Inflammation
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 25, 2023

    Periodontal Inflammation Trial in Ajman (saliva analysis for Toll like receptor activity)

    Completed
    • Periodontal Inflammation
    • saliva analysis for Toll like receptor activity
    • Ajman, Dubai, United Arab Emirates
      Ajman University
    Dec 16, 2019

    SNPs in p53 and p53 Response Elements on Inflammatory Response

    Completed
    • HIV-1 Seropositive
    • +3 more
      • Research Triangle Park, North Carolina
        NIEHS Clinical Research Unit (CRU)
      Jan 21, 2023

      Stage IIA Skin Melanoma, Stage IIB Skin Melanoma, Stage IIC Skin Melanoma Trial in Rochester (biological, drug, other)

      Completed
      • Stage IIA Skin Melanoma
      • +6 more
      • MART-1 Antigen
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 13, 2020